Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Non Operating Interest Expenses (2009 - 2010)

Updated

Kazia Therapeutics' Non Operating Interest Expenses came in at -$576,858 for FY2017 (year ended Jun 30, 2017).

Analysis

Kazia Therapeutics (KZIA) Non Operating Interest Expenses (2009 - 2010) Analysis & Trends

Going back to FY2009, Kazia Therapeutics' Non Operating Interest Expenses data covers 7 fiscal years.

  • The FY2017 figure represents the lowest annual Non Operating Interest Expenses since FY2014.
  • Per Business Quant, earlier fiscal years put Non Operating Interest Expenses at -$51,936 in FY2015, -$645,172 in FY2014 and -$538,396 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 217.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 269.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2010 -14,144.58
Dec 31, 2009 -9,998.47
API Access

Kazia Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KZIA&period=max&api_key=YOUR_API_KEY